Skip to main content
SpringerLink
Log in

Lobuläre Neoplasie und invasives lobuläres Mammakarzinom

Lobular neoplasms and invasive lobular breast cancer

  • Schwerpunkt
  • Published:
Der Pathologe Aims and scope Submit manuscript

Zusammenfassung

Der Begriff der lobulären Neoplasie (LN) beinhaltet die atypische lobuläre Hyperplasie (ALH) und das lobuläre Carcinoma in situ (LCIS). Er umfasst ein Spektrum morphologisch heterogener, aber klinisch und molekularbiologisch verwandter Läsionen. Die LN gilt als nichtobligate Vorläuferläsion des invasiven Mammakarzinoms und gleichzeitig als Indikatorläsion für ein ipsi- und kontralaterales Karzinomrisiko der Patientin. Die seltenen pleomorphen und floriden Varianten des LCIS werden vom klassischen LCIS abgegrenzt. Das invasive lobuläre Mammakarzinom (ILC) unterscheidet sich vom nicht speziellen Typ des invasiven Mammakarzinoms (NST) durch E-Cadherin-Inaktivierung, Verlust der E-Cadherin-vermittelten Zelladhäsion und dem dadurch bedingten diskohäsiven Zellbild beim klassischen ILC. Variante Formen des ILC können vom klassischen Typ abweichende molekulare Eigenschaften und bei den gering differenzierten Formen solide und pleomorphe Differenzierungsmuster aufweisen. Für die Prognoseabschätzung des ILC sind Grading und die Abgrenzung von Varianten wichtige Parameter.

Abstract

The term lobular neoplasia (LN) comprises both atypical lobular hyperplasia (ALH), and lobular carcinoma in situ (LCIS) and thus a spectrum of morphologically heterogeneous but clinically and biologically related lesions. LN is regarded as a nonobligatory precursor lesion of invasive breast cancer and at the same time as an indicator lesion for ipsilateral and contralateral breast cancer risk of the patient. Rare pleomorphic or florid variants of LCIS must be differentiated from classical LCIS. The classical type of invasive lobular carcinoma (ILC) can be distinguished from the non-special type of invasive breast cancer (NST) by E-cadherin inactivation, loss of E-cadherin related cell adhesion and the subsequent discohesive growth pattern. Variant forms of ILC may show different molecular features, and solid and pleomorphic differentiation patterns in cases of high grade variants. Important parameters for the prognostic assessment of ILC are tumor grading and the recognition of morphological variants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Andersen JA (1974) Lobular carcinoma in situ. A long-term follow-up in 52 cases. Acta Pathol Microbiol Scand A 82:519–533

    CAS  PubMed  Google Scholar 

  2. Anderson WF, Pfeiffer RM, Dores GM et al (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 15:1899–1905

    Article  PubMed  Google Scholar 

  3. Aulmann S, Penzel R, Longerich T et al (2008) Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer. Breast Cancer Res Treat 107:331–335

    Article  PubMed  Google Scholar 

  4. Bagaria SP, Shamonki J, Kinnaird M et al (2011) The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma? Ann Surg Oncol 18:1845–1851

    Article  PubMed  Google Scholar 

  5. Bertucci F, Orsetti B, Negre V et al (2008) Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Oncogene 27:5359–5372

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Borst MJ, Ingold JA (1993) Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 114:637–641

    CAS  PubMed  Google Scholar 

  7. Bratthauer GL, Tavassoli FA (2002) Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 440:134–138

    Article  PubMed  Google Scholar 

  8. Brogi E, Murray MP, Corben AD (2010) Lobular carcinoma, not only a classic. Breast J 16(Suppl 1):S10–S14

    Article  PubMed  Google Scholar 

  9. Chen YY, Hwang ES, Roy R et al (2009) Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol 33:1683–1694

    Article  PubMed Central  PubMed  Google Scholar 

  10. Choi YJ, Pinto MM, Hao L et al (2008) Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma. Mod Pathol 21:1224–1237

    Article  CAS  PubMed  Google Scholar 

  11. Christgen M, Noskowicz M, Schipper E et al (2013) Oncogenic PIK3CA mutations in lobular breast cancer progression. Genes Chromosomes Cancer 52:69–80

    Article  CAS  PubMed  Google Scholar 

  12. Claus EB, Stowe M, Carter D et al (2003) The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry. Breast 12:451–456

    Article  PubMed  Google Scholar 

  13. Coopey SB, Mazzola E, Buckley JM et al (2012) The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat 136:627–633

    Article  CAS  PubMed  Google Scholar 

  14. Da Silva L, Parry S, Reid L et al (2008) Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am J Surg Pathol 32:773–783

    Article  Google Scholar 

  15. Dabbs DJ, Bhargava R, Chivukula M (2007) Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol 31:427–437

    Article  PubMed  Google Scholar 

  16. Dabbs DJ, Schnitt SJ, Geyer FC et al (2013) Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Am J Surg Pathol 37:e1–e11

    Article  PubMed  Google Scholar 

  17. Ellis IO, Galea M, Broughton N et al (1992) Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20:479–489

    Article  CAS  PubMed  Google Scholar 

  18. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410

    Article  CAS  PubMed  Google Scholar 

  19. Esposito NN, Chivukula M, Dabbs DJ (2007) The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study. Mod Pathol 20:130–138

    Article  CAS  PubMed  Google Scholar 

  20. Flagiello D, Gerbault-Seureau M, Sastre-Garau X et al (1998) Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer. Genes Chromosomes Cancer 23:300–306

    Article  CAS  PubMed  Google Scholar 

  21. Foote FW Jr, Stewart FW (1946) A histologic classification of carcinoma of the breast. Surgery 19:74–99

    PubMed  Google Scholar 

  22. Foote FW, Stewart FW (1941) Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 17:491–495

    CAS  PubMed  Google Scholar 

  23. Frolik D, Caduff R, Varga Z (2001) Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas. Histopathology 39:503–513

    Article  CAS  PubMed  Google Scholar 

  24. Green I, Mccormick B, Cranor M et al (1997) A comparative study of pure tubular and tubulolobular carcinoma of the breast. Am J Surg Pathol 21:653–657

    Article  CAS  PubMed  Google Scholar 

  25. Gruel N, Lucchesi C, Raynal V et al (2010) Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma. Eur J Cancer 46:2399–2407

    Article  CAS  PubMed  Google Scholar 

  26. Haagensen CD, Lane N, Lattes R et al (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737–769

    Article  CAS  PubMed  Google Scholar 

  27. Hanby A, Hughes T (2008) In situ and invasive lobular neoplasia of the breast. Histopathology 52:58–66

    Article  CAS  PubMed  Google Scholar 

  28. Harris M, Howell A, Chrissohou M et al (1984) A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 50:23–30

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Hilleren DJ, Andersson IT, Lindholm K et al (1991) Invasive lobular carcinoma: mammographic findings in a 10-year experience. Radiology 178:149–154

    CAS  PubMed  Google Scholar 

  30. Houssami N, Turner R, Morrow M (2013) Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg 257:249–255

    Article  PubMed  Google Scholar 

  31. Hussain M, Cunnick GH (2011) Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast – a review. Eur J Surg Oncol 37:279–289

    Article  CAS  PubMed  Google Scholar 

  32. Hwang E, Nyante S, Yi Chen Y et al (2004) Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 100:2562–2572

    Article  PubMed  Google Scholar 

  33. Iorfida M, Maiorano E, Orvieto E et al (2012) Invasive lobular breast cancer: subtypes and outcome. Breast Cancer Res Treat 133:713–723

    Article  CAS  PubMed  Google Scholar 

  34. Jain S, Fisher C, Smith P et al (1993) Patterns of metastatic breast cancer in relation to histological type. Eur J Cancer 29A:2155–2157

    Article  CAS  PubMed  Google Scholar 

  35. Kramer R, Brown P (2004) Should tamoxifen be used in breast cancer prevention? Drug Saf 27:979–989

    Article  CAS  PubMed  Google Scholar 

  36. Kuroda H, Tamaru J, Takeuchi I et al (2006) Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast. Virchows Arch 448:500–505

    Article  CAS  PubMed  Google Scholar 

  37. Lakhani SR, Ellis I, Schnitt S et al (2012) WHO classification of tumours of the breast. IARC Press, Lyon

  38. Lewis JL, Lee DY, Tartter PI (2012) The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast. Ann Surg Oncol 19:4124–4128

    Article  PubMed  Google Scholar 

  39. Li CI, Anderson BO, Daling JR et al (2002) Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat 75:259–268

    Article  PubMed  Google Scholar 

  40. Li CI, Uribe DJ, Daling JR (2005) Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93:1046–1052

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Mann RM, Veltman J, Barentsz JO et al (2008) The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast. Eur J Surg Oncol 34:135–142

    Article  CAS  PubMed  Google Scholar 

  42. Marchio C, Sapino A, Arisio R et al (2006) A new vision of tubular and tubulo-lobular carcinomas of the breast, as revealed by 3-D modelling. Histopathology 48:556–562

    Article  CAS  PubMed  Google Scholar 

  43. Masannat YA, Bains SK, Pinder SE et al (2013) Challenges in the management of pleomorphic lobular carcinoma in situ of the breast. Breast 22:194–196

    Article  PubMed  Google Scholar 

  44. Middleton LP, Palacios DM, Bryant BR et al (2000) Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 24:1650–1656

    Article  CAS  PubMed  Google Scholar 

  45. Mitze M, Meyer F, Goepel E et al (1991) Besonderheiten in Klinik und Verlauf beim invasiven lobulären Mammakarzinom. Geburtshilfe Frauenheilkd 51:973–979

    Article  CAS  PubMed  Google Scholar 

  46. Moatamed NA, Apple SK (2006) Extensive sampling changes T-staging of infiltrating lobular carcinoma of breast: a comparative study of gross versus microscopic tumor sizes. Breast J 12:511–517

    Article  PubMed  Google Scholar 

  47. Monhollen L, Morrison C, Ademuyiwa FO et al (2012) Pleomorphic lobular carcinoma: a distinctive clinical and molecular breast cancer type. Histopathology 61:365–377

    Article  PubMed  Google Scholar 

  48. Murray MP, Luedtke C, Liberman L et al (2013) Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision. Cancer 119:1073–1079

    Article  PubMed  Google Scholar 

  49. Newstead GM, Baute PB, Toth HK (1992) Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis. Radiology 184:623–627

    CAS  PubMed  Google Scholar 

  50. Nishizaki T, Chew K, Chu L et al (1997) Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 74:513–517

    Article  CAS  PubMed  Google Scholar 

  51. Oppong BA, King TA (2011) Recommendations for women with lobular carcinoma in situ (LCIS). Oncology (Williston Park) 25:1051–1056, 1058

    Google Scholar 

  52. Orvieto E, Maiorano E, Bottiglieri L et al (2008) Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution. Cancer 113:1511–1520

    Article  PubMed  Google Scholar 

  53. Ottesen GL, Graversen HP, Blichert-Toft M et al (1993) Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 17:14–21

    Article  CAS  PubMed  Google Scholar 

  54. Page DL, Kidd TE Jr, Dupont WD et al (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22:1232–1239

    Article  CAS  PubMed  Google Scholar 

  55. Page DL, Schuyler PA, Dupont WD et al (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361:125–129

    Article  PubMed  Google Scholar 

  56. Pereira H, Pinder SE, Sibbering DM et al (1995) Pathological prognostic factors in breast cancer. IV: should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 27:219–226

    Article  CAS  PubMed  Google Scholar 

  57. Pestalozzi BC, Zahrieh D, Mallon E et al (2008) Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol 26:3006–3014

    Article  PubMed  Google Scholar 

  58. Qureshi HS, Linden MD, Divine G et al (2006) E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. Am J Clin Pathol 125:377–385

    Article  PubMed  Google Scholar 

  59. Rakha EA, El-Sayed ME, Menon S et al (2008) Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 111:121–127

    Article  PubMed  Google Scholar 

  60. Rakha EA, El-Sayed ME, Powe DG et al (2008) Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer 44:73–83

    Article  PubMed  Google Scholar 

  61. Reis-Filho JS, Simpson PT, Jones C et al (2005) Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol 207:1–13

    Article  CAS  PubMed  Google Scholar 

  62. Rosen P, Kosloff C, Lieberman P et al (1978) Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2:225–251

    Article  CAS  PubMed  Google Scholar 

  63. Ross DS, Hoda SA (2011) Microinvasive (T1mic) lobular carcinoma of the breast: clinicopathologic profile of 16 cases. Am J Surg Pathol 35:750–756

    Article  PubMed  Google Scholar 

  64. Sakr RA, Poulet B, Kaufman GJ et al (2011) Clear margins for invasive lobular carcinoma: a surgical challenge. Eur J Surg Oncol 37:350–356

    Article  CAS  PubMed  Google Scholar 

  65. Sastre-Garau X, Jouve M, Asselain B et al (1996) Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 77:113–120

    Article  CAS  PubMed  Google Scholar 

  66. Shin SJ, Lal A, De Vries S et al (2013) Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ. Hum Pathol 44:1998–2009

    Article  CAS  PubMed  Google Scholar 

  67. Silverstein MJ, Lewinsky BS, Waisman JR et al (1994) Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73:1673–1677

    Article  CAS  PubMed  Google Scholar 

  68. Simcha I, Shtutman M, Salomon D et al (1998) Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin. J Cell Biol 141:1433–1448

    Article  CAS  PubMed  Google Scholar 

  69. Sinn HP, Helmchen B, Aulmann S (2006) Konzept und Problematik der lobularen Neoplasie. Pathologe 27:373–380

    Article  CAS  PubMed  Google Scholar 

  70. Sinn HP, Kellerhoff NM, Kellerhoff R et al (1997) Subtypisierung und Prognoseabschätzung beim invasiven lobulären Mammakarzinom. Pathologe 18:37–44

    Article  CAS  PubMed  Google Scholar 

  71. Slanger TE, Chang-Claude JC, Obi N et al (2009) Menopausal hormone therapy and risk of clinical breast cancer subtypes. Cancer Epidemiol Biomarkers Prev 18:1188–1196

    Article  CAS  PubMed  Google Scholar 

  72. Talman ML, Jensen MB, Rank F (2007) Invasive lobular breast cancer. Prognostic significance of histological malignancy grading. Acta Oncol 46:803–809

    Article  PubMed  Google Scholar 

  73. Toikkanen S, Pylkkanen L, Joensuu H (1997) Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer 76:1234–1240

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  74. Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571

    Article  PubMed  Google Scholar 

  75. Vos CB, Cleton-Jansen AM, Berx G et al (1997) E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76:1131–1133

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  76. Wachtel MS, Halldorsson A, Dissanaike S (2011) Nottingham grades of lobular carcinoma lack the prognostic implications they bear for ductal carcinoma. J Surg Res 166:19–27

    Article  PubMed  Google Scholar 

  77. Wasif N, Maggard MA, Ko CY et al (2010) Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes. Ann Surg Oncol 17:1862–1869

    Article  PubMed  Google Scholar 

  78. Weinstein SP, Orel SG, Heller R et al (2001) MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 176:399–406

    Article  CAS  PubMed  Google Scholar 

  79. Wheeler DT, Tai LH, Bratthauer GL et al (2004) Tubulolobular carcinoma of the breast: an analysis of 27 cases of a tumor with a hybrid morphology and immunoprofile. Am J Surg Pathol 28:1587–1593

    Article  PubMed  Google Scholar 

  80. Winchester DJ, Chang HR, Graves TA et al (1998) A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg 186:416–422

    Article  CAS  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. H.-P. Sinn, B. Helmchen, J. Heil und S. Aulmann geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Pathologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Deutschland

    H.-P. Sinn & S. Aulmann

  2. Stadtspital Triemli, Zürich, Schweiz

    B. Helmchen

  3. Klinik für Frauenheilkunde, Universität Heidelberg, Heidelberg, Deutschland

    J. Heil

Authors
  1. H.-P. Sinn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Helmchen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Heil
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Aulmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H.-P. Sinn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sinn, HP., Helmchen, B., Heil, J. et al. Lobuläre Neoplasie und invasives lobuläres Mammakarzinom. Pathologe 35, 45–53 (2014). https://doi.org/10.1007/s00292-013-1840-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-013-1840-8

Schlüsselwörter

Keywords

Search

Navigation